Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
|
|
|
11.
|
|
|
|
12.
|
|
|
|
13.
|
|
|
|
14.
|
|
|
|
15.
|
|
|
|
16.
|
|
|
|
17.
|
|
|
|
18.
|
Safety, pharmacokinetics, and pharmacodynamics of ivacaftor in patients aged 2-5 years with cystic fibrosis and a CFTR gating mutation (KIWI): an open-label, single-arm study. [electronic resource] by
- Davies, Jane C
- Cunningham, Steve
- Harris, William T
- Lapey, Allen
- Regelmann, Warren E
- Sawicki, Gregory S
- Southern, Kevin W
- Robertson, Sarah
- Green, Yulia
- Cooke, Jon
- Rosenfeld, Margaret
Producer: 20170110
In:
The Lancet. Respiratory medicine vol. 4
Availability: No items available.
|
|
|
19.
|
|
|
|
20.
|
An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2-5 years (KLIMB). [electronic resource] by
- Rosenfeld, Margaret
- Cunningham, Steve
- Harris, William T
- Lapey, Allen
- Regelmann, Warren E
- Sawicki, Gregory S
- Southern, Kevin W
- Chilvers, Mark
- Higgins, Mark
- Tian, Simon
- Cooke, Jon
- Davies, Jane C
Producer: 20201109
In:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society vol. 18
Availability: No items available.
|